Showing results (191-200 of 223) with videos related to

Sort By:
Pageof 23
Bone Marrow Transplantation|October 2, 2020
Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working partyJohannes Schetelig, Patrice Chevallier, Michel van Gelder, et al.
Future Oncology (London, England)|December 13, 2023
Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatmentJennifer R Brown, Barbara Eichhorst, Peter Hillmen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2024
European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free RemissionFrancois-Xavier Mahon, Markus Pfirrmann, Stéphanie Dulucq, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2013
Prespecified candidate biomarkers identify follicular lymphoma patients who achieved longer progression-free survival with bortezomib-rituximab versus rituximabBertrand Coiffier, Weimin Li, Erin D Henitz, et al.
The New England Journal of Medicine|December 13, 2022
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic LeukemiaJennifer R Brown, Barbara Eichhorst, Peter Hillmen, et al.
The Journal of Clinical Investigation|October 22, 2024
FoxO1/Rictor axis induces a nongenetic adaptation to ibrutinib via Akt activation in chronic lymphocytic leukemiaLaura Ondrisova, Vaclav Seda, Krystof Hlavac, et al.
Leukemia|June 8, 2022
Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapyMatthew Salmon, Helen E White, Hana Zizkova, et al.
Bone Marrow Transplantation|March 28, 2023
The European landscape on allogeneic haematopoeietic cell transplantation in Chronic Lymphocytic Leukaemia between 2009 and 2019: a perspective from the Chronic Malignancies Working Party of the EBMTOlivier Tournilhac, Michel van Gelder, Dirk-Jan Eikema, et al.
Leukemia|February 19, 2026
Repression of miR-29 via MYC leads to increased CD40 signaling in transformed follicular lymphomaDaniel Filip, Katerina Litzmanova, Androniki Michaelou, et al.
Communications Medicine|May 17, 2023
Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profilesJan-Niklas Eckardt, Christoph Röllig, Klaus Metzeler, et al.
Pageof 23